HC Wainwright Begins Coverage on ImmunityBio (NASDAQ:IBRX)
Equities research analysts at HC Wainwright began coverage on shares of ImmunityBio (NASDAQ:IBRX – Get Free Report) in a report issued on Thursday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $8.00 price target on the stock. HC Wainwright’s target price indicates a potential upside of 166.67% from the company’s previous close. […]
Equities research analysts at HC Wainwright began coverage on shares of ImmunityBio (NASDAQ:IBRX – Get Free Report) in a report issued on Thursday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $8.00 price target on the stock. HC Wainwright’s target price indicates a potential upside of 166.67% from the company’s previous close. […]
